Bon Natural Life
2 hedge funds and large institutions have $20K invested in Bon Natural Life in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
89% less capital invested
Capital invested by funds: $176K → $20K (-$156K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$158K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
BON Hedge Fund Activity: Q4 2021 in Review
2 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q4 2021, worth a combined $20K — down 89% from $176K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BON and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $15.9K. The largest seller was Marshall Wace, exiting entirely with an estimated $158K sold.
- 2 institutional investors held Bon Natural Life (BON) as of Q4 2021, down from 3 in Q3 2021.
- Funds reported $20K of Bon Natural Life stock for Q4 2021, down 89% quarter-over-quarter.
- 1 fund opened new Bon Natural Life positions in Q4 2021 and 2 closed out, a net change of -1 holder.
- The largest Bon Natural Life buyer in Q4 2021 was UBS Group, an estimated $15.9K added.
- The largest Bon Natural Life seller in Q4 2021 was Marshall Wace, an estimated $158K sold.
Based on aggregated 13F filings for Q4 2021.